Differential effects of inhibitors of cyclooxygenase (cyclooxygenase 1 and cyclooxygenase 2) in acute inflammation

European Journal of Pharmacology

Volumn 355, Issue 2-3, 1998, Pages 211-217

  Gilroy, Derek W ^a   Tomlinson, Annette ^a   Willoughby, Derek A ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Acute inflammation; Aspirin; Cyclooxygenase 1; Cyclooxygenase 2; Leukotriene B4; Nimesulide; NS 398; Piroxicam

Indexed keywords

ACETYLSALICYLIC ACID; CARRAGEENAN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; LEUKOTRIENE B4; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NIMESULIDE; PIROXICAM; PROSTAGLANDIN SYNTHASE INHIBITOR; THROMBOXANE B2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; INFLAMMATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PLEURISY; PRIORITY JOURNAL; THROMBOCYTE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; ISOENZYMES; MALE; MEMBRANE PROTEINS; NITROBENZENES; PIROXICAM; PLEURAL EFFUSION; PLEURISY; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, WISTAR; SULFONAMIDES;

EID: 0031667976     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00508-1     Document Type: Article

References (36)

1. Bateman, D.N., 1994. NASIDs: time to re-evaluate gut toxicity. Lancet 343, 1051-1052.
2. Battistini, B., Botting, R., Bakhle, Y.S., 1994. COX-1 and COX-2: towards the development of more selective NSAIDs. Drugs News Perspect. 7, 501-512.
3. Casolaro, V., Meliota, S., Marino, O., Patella, V., de Paulis, A., Guidi, G., Marone, G., 1993. Nimesulide, a sulphonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from basophils and mast cells. J. Pharmacol. Exp. Ther. 267, 1375-1385.
4. Crofford, L.J., Wilder, R.L., Ristamaki, A.P., Sano, H., Remmers, E.F., Epps, H.R., Hla, T., 1994. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues: effects of interleukin-1 beta, phorbol esters and corticosteroids. J. Clin. Invest. 93, 1095-1101.
5. Dworski et al., 1989.
6. Fonteh, A.N., Winkler, J.D., Trophy, T.J., Heravi, J., Undem, B.J., Chilton, F.H., 1993. Influence of isoproterenol and phosphodiesterase inhibitors on platelet activation factor biosynthesis in the human neutrophil. J. Immunol. 151, 339-350.
7. Ford-Hutchinson, A.W., 1983. Neutrophil aggregating properties of PAF-acether and leukotriene B4. Int. J. Immunopharmacol. 5, 17-21.
8. Ford-Hutchinson, A.W., Bray, M.A., Doig, M.V., Shipley, M.E., Smith, M.J., 1980. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 286, 264-265.
9. Fretland, D.J., Widomski, D., Tsai, B.S., Zematis, J.M., Levin, S., Djuric, S.W., Shone, R.L., Gagnelli, T.S., 1990. Effects of the leukotriene B4 antagonist SC-41930 on colonic inflammation in rat, guinea pig and rabbit. J. Pharmacol. Exp. Ther. 255, 572-576.
10. Futaki, N., Yoshikawa, K., Hamasaka, Y., Arai, I., Higuchi, S., Iizuka, H., Otomo, S., 1993a. NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions. Gen. Pharmacol. 24, 105-110.
11. Futaki, N., Arai, I., Hamasaka, Y., Takahashi, S., Higuchi, S., Otomo, S., 1993b. Selective inhibition of NS-398 on prostanoid production in inflamed tissue in rat carrageenan-air-pouch inflammation. J. Pharm. Pharmacol. 45, 753-755.
12. Futaki, N., Takahashi, S., Yokoyama, M., Arai, I., Higuchi, S., Otomo, S., 1994. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47, 55-59.
13. Goetzl, E.J., 1980. Mediators of immediate hypersensitivity derived from arachidonic acid. N. Engl. J. Med. 303, 822-825.
14. Grossman, C.J., Wiseman, J., Lucas, F.S., Trevethick, M.A., Birch, P.J., 1995. Inhibition of constitutive and inducible cyclooxygenase activity in human platelets and mononuclear cells by NSAIDs and Cox 2 inhibitors. Inflammation Res. 44, 253-257.
15. 2 formation in the rat carrageenin-induced pleurisy. Prostaglandins 51, 19-33.
16. Hubbard, R.C., Mehlisch, D.R., Jasper, D.R., Nugent, M.J., Y.U., S., Isakson, P.C., 1996. SC-58125, A highly selective inhibitor of COX-2, is an effective analgesic in an acute post-surgical pain model. J. Invest. Med. 44, 293.
17. Kujubu, D.A., Herschman, H.R., 1992. Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene. J. Biol. Chem. 267, 7991-7994.
18. Langenbach, R., Chulada, P.C., Lee, C.A., Morham, S.G., Tiano, H.F., 1996. Inflammatory responses in cyclooxygenase 1 and cyclooxygenase 2 deficient mice. J. Leucocyte Biol. Supplement, 15.
19. Magni, E., 1993. The effects of nimesulide on prostanoid formation. Drugs 46, 10-14.
20. Masferrer, J.L., Zweifel, B.S., Manning, P.T., Hauser, S.D., Leahy, K.M., Smith, W.G., Isakson, P.C., Seibert, K., 1994. Selective inhibition of inducible cyclooxygenase 2 in vivo is anti-inflammatory and nonulcerogenic. Proc. Natl. Acad. Sci. USA 91, 3228-3232.
21. Meade, E.A., Smith, W.L., DeWitt, D.L., 1993. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 268, 6610-6614.
22. Mitchell, J.A., Akarasereenont, P., Thiemermann, C., Flower, R.J., Vane, J.R., 1993. Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxyggenase. Proc. Natl. Acad. Sci. USA 90, 11693-11697.
23. Morham, S.G., Langenbach, R., Loftin, C.D., Tiano, H.F., Vouloumanos, N., Jennette, J.C., Mahler, J.F., Kluckman, K.D., Ledford, A. et al., 1995. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 83, 473-482.
24. 4 on the micro vasculature of the guinea-pig skin. Prostaglandins 21, 315-321.
25. Puignero, V., Queralt, J., 1997. Effect of topically applied cyclooxygenase-2 selective inhibitors on arachidonic acid and tetradeconylphorbol acetate-induced dermal inflammation in the mouse. Inflammation 21, 431-442.
26. Quellet, M., Percival, M.D., 1995. Effect of inhibitor time-dependency on selectivity towards cyclooxygenase isoforms. Biochem. J. 306, 247-251.
27. Sugio, K., Ohuchi, K., Sugata, M., Tsurufuji, S., 1981. Suppression by dexamethasone of vascular permeability responses induced with leukotrienes C and D in the rat skin. Prostaglandins 21, 649-653.
28. Tomlinson, A., Appleton, I., Moore, A.R., Gilroy, D.W., Willis, D., Mitchell, J.A., Willoughby, D.A., 1994. Cyclo-oxygenase and nitric oxide synthase isoforms in rat carrageenin-induced pleurisy. Br. J. Pharmacol. 113, 693-698.
29. 4 in activated neutrophils by nimesulide due to an elevation of intracellular cyclic adenosine monophosphate. Arzneimittelforschung 45, 1110-1114.
30. Vane, J.R., 1994. Towards a better aspirin. Nature 367, 215-216.
31. Velo, G.P., Dunn, C.J., Giroud, J.P., Timsit, J., Willoughby, D.A., 1973. Distribution of prostaglandins in inflammatory exudate. J. Pathol. 111, 149-158.
32. Wilborn, J., DeWitt, D.L., Peters-Golden, M., 1995. Expression and role of cyclooxygenase isoforms in alveolar and peritoneal macrophages. Am. J. Physiol. 268, L294-L301.
33. Williams, T.J., Piper, P.J., 1980. The action of chemically pure SRS-A on the microcirculation in vivo. Prostaglandins 19, 779-789.
34. Willoughby, D.A., 1975. Human arthritis applied to animals models: towards a better therapy. Heberden oration. Annals of the Rheumatic Diseases 34, 471-478.
35. Xie, W., Chapman, J.G., Robertson, D.L., Erikson, R.L., Simmons, D.L., 1991. Expression of a mitogen responsive gene encoding prostaglandin synthase is regulated mRNA splicing. Proc. Natl. Acad. Sci. USA 88, 2692-2696.
36. Zarif, A., Eiznhamer, D., Callaghan, C., Doria, M.I., Broutman, L., Keshavarzian, A., 1996. The effects of the selective 5-lipoxygenase inhibitor, Zileuton, on tissue damage in acute colonic inflammation in rats. Inflammation 20, 217-227.